Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses track

MLA

Ulf, Schnetzke, et al. “Paradoxical MAPK-Activation in Response to Treatment with Tyrosine Kinase Inhibitors in CML: Flow Cytometry Loses Track.” Cytometry. Part B, Clinical Cytometry, vol. 86, no. 4, Feb. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........71131795357cbc3aeae4d3e7bc64051b&authtype=sso&custid=ns315887.

APA

Ulf, S., Mike, F., Jochen J, F., Andreas, F., Joachim H, C., Andreas, H., & Paul, L. R. (2013). Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses track. Cytometry. Part B, Clinical Cytometry, 86(4).

Chicago

Ulf, Schnetzke, Fischer Mike, Frietsch Jochen J, Finkensieper Andreas, Clement Joachim H, Hochhaus Andreas, and La Rosée Paul. 2013. “Paradoxical MAPK-Activation in Response to Treatment with Tyrosine Kinase Inhibitors in CML: Flow Cytometry Loses Track.” Cytometry. Part B, Clinical Cytometry 86 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........71131795357cbc3aeae4d3e7bc64051b&authtype=sso&custid=ns315887.